retatrutide peptide study 6mg Reta (RUO) | GIP/GLP-1/GCG Agonist

Recent statistics reveal that over 37% of Franklin Countys population is obese and 69% of the population is overweight

In the SURPASS-2 study, the three doses of tirzepatide (5, 10, and 15 mg once weekly) were tested with the GLP-1RA semaglutide (1 mg once weekly) as a comparator in patients not optimally controlled on monotherapy with metformin (71)

There is still uncertainty about what happens after Bridge expires at the end of 2027, raising questions about whether beneficiaries who start treatment will be able to stay on it long term

doi: 10.1093/asj/sjad364

It makes a person feel full

From FDA approval criteria and clinical trial enrollment standards to the wildly inconsistent rules insurance companies use to approve or reject coverage, this guide covers the full picture